(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 3.82% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 11.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.8%.
Elanco Animal Health's revenue in 2023 is $4,411,000,000.On average, 6 Wall Street analysts forecast ELAN's revenue for 2023 to be $2,250,930,069,564, with the lowest ELAN revenue forecast at $2,228,319,068,518, and the highest ELAN revenue forecast at $2,277,910,892,334. On average, 6 Wall Street analysts forecast ELAN's revenue for 2024 to be $2,336,610,525,680, with the lowest ELAN revenue forecast at $2,297,954,070,131, and the highest ELAN revenue forecast at $2,355,968,000,293.
In 2025, ELAN is forecast to generate $2,428,765,592,791 in revenue, with the lowest revenue forecast at $2,402,271,398,087 and the highest revenue forecast at $2,455,259,787,495.